NCT06899243View on ClinicalTrials.gov

Efficacy of CL22205 on Bone Mineral Density and Menopausal Symptoms

NANot yet recruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 25, 2025

Primary Completion Date

May 10, 2026

Study Completion Date

August 30, 2026

Conditions
Menopausal Symptoms
Interventions
DIETARY_SUPPLEMENT

CL22205

200 mg, Route : Oral, One capsule a day after breakfast for 360 days

OTHER

Placebo

Route : Oral, One capsule a day after breakfast for 360 days

All Listed Sponsors
lead

Eetho Brands, Inc

INDUSTRY

NCT06899243 - Efficacy of CL22205 on Bone Mineral Density and Menopausal Symptoms | Biotech Hunter | Biotech Hunter